Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;30(7):4528-4537.
doi: 10.1111/odi.14907. Epub 2024 Feb 29.

Anti-resorptive therapy and MRONJ. A survey of the Italian Society of Periodontology and Implantology

L Landi  1 , G Oteri  2 , L Barbato  3 , N Discepoli  4 , A M Carrassi  5 , M Rigoni  5 , F Cairo  3 , R Cavalcanti  6   7 , A Crea  8 , R Gianserra  9 , N M Sforza  10
Affiliations

Anti-resorptive therapy and MRONJ. A survey of the Italian Society of Periodontology and Implantology

L Landi et al. Oral Dis. 2024 Oct.

Abstract

Objectives: Anti-resorptive agents have been linked to the development of MRONJ in patients undergoing dental surgical procedures. This survey aims to explore the level of knowledge and experience of Italian Society of Periodontology and Implantology members in the management of patients treated with anti-resorptive agents and with the risk of developing MRONJ.

Materials and methods: An 18-item questionnaire was submitted by e-mail to the SIdP members. Statistical analyses were carried out. Continuous variables were described as mean ± standard deviation (SD) or median, and first and third quartile according to distribution's normality. Normality of data was checked with Shapiro-Wilk test.

Results: Four hundred and fifty-one questionnaires were returned by e-mail (32%). Most of the respondents were private practitioners (81.8%). Only 47.7% declared to be highly confident in managing patients on anti-resorptive therapy while 92.5% reported to have performed tooth extractions and 52.3% implant surgery in patients under anti-resorptive therapy for osteometabolic disorders. One or more MRONJ-affected patients were encountered by 63.2% of the respondents.

Conclusions: This survey highlights the need to develop a "dedicated" program both for dentists and prescribers to improve the level of cooperation and to increase the level of awareness of patients treated with anti-resorptive agents.

Keywords: anti‐resorptive therapy; bisphosphonates denosumab; dentists; medication‐related osteo‐necrosis of the jaws; periodontitis.

PubMed Disclaimer

References

REFERENCES

    1. Acharya, S., Patil, V., Ravindranath, V., Kudva, A., & Nikhil, K. (2022). Medication‐related osteonecrosis of the jaw: Knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals. Journal of Medicine and Life, 15(3), 368–373. https://doi.org/10.25122/jml‐2021‐0085
    1. Aimetti, M., Perotto, S., Castiglione, A., Mariani, G. M., Ferrarotti, F., & Romano, F. (2015). Prevalence of periodontitis in an adult population from an urban area in North Italy: Findings from a cross‐sectional population‐based epidemiological survey. Journal of Clinical Periodontology, 42(7), 622–631. https://doi.org/10.1111/jcpe.12420
    1. AIOM. (2022). I Numeri del Cancro in Italia (p. 2022). AIOM. https://www.aiom.it/wp‐content/uploads/2022/12/2022_AIOM_NDC‐web.pdf
    1. Al‐Eid, R., Alduwayan, T., Bin Khuthaylah, M., & Al Shemali, M. (2020). Dentists' knowledge about medication‐related osteonecrosis of the jaw and its management. Heliyon., 6(7), e04321. https://doi.org/10.1016/j.heliyon.2020.e04321
    1. Al‐Samman, A. A., & Al‐Ani, R. S. (2019). Across‐sectional survey on medication‐related osteonecrosis of the jaws' knowledge and awareness in a sample of dental society. Journal of Cranio‐Maxillo‐Facial Surgery, 47(6), 926–931. https://doi.org/10.1016/j.jcms.2019.02.006

Substances

LinkOut - more resources